Bellinger Andrew

CIK 00018641161 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001864116

Recent Transactions

32 trades

Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-02-14+180,000→ 180,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2024-02-14+45,000→ 45,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-02-14+182,800→ 182,800 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-12-14−36,000→ 179,994 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-12-14$2.87/sh+36,000→ 42,629 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-12-01$22.95/sh−865→ 6,629 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-28$39.90/sh−10,000→ 6,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-10-28$1.48/sh+10,000→ 16,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-10-28−10,000→ 86,995 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-09-23$35.59/sh−13,368→ 6,629 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-09-23$35.31/sh−36,798→ 9,831 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-09-23−20,000→ 23,198 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-09-23$1.48/sh+40,000→ 46,629 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-09-23$36.03/sh−3,202→ 6,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-09-23−40,000→ 96,995 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-09-23$34.67/sh−6,632→ 19,997 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-09-23$1.48/sh+20,000→ 26,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-07-20$1.39/sh+20,000→ 26,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-20−20,000→ 1,599 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-07-20$34.90/sh−20,000→ 6,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-07-13$1.48/sh+10,000→ 16,629 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-07-13$24.90/sh−10,000→ 6,629 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-13−10,000→ 136,995 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-02-11+125,000→ 125,000 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2021-12-22−15,000→ 146,995 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2021-12-22$1.48/sh+15,000→ 20,000 total
Sale
Verve Therapeutics, Inc.
Common Stock
2021-12-22$37.42/sh−1,968→ 18,032 total
Sale
Verve Therapeutics, Inc.
Common Stock
2021-12-22$38.60/sh−8,161→ 9,871 total
Sale
Verve Therapeutics, Inc.
Common Stock
2021-12-22$39.37/sh−4,871→ 5,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2021-12-16+55,000→ 55,000 total
Purchase
Verve Therapeutics, Inc.
Common Stock
2021-06-21$19.00/sh+5,000→ 5,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2021-06-17+21,599→ 21,599 total

Companies

Verve Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

Address

C/O VERVE THERAPEUTICS, INC. 500 TECHNOLOGY SQUARE, SUITE 901

CAMBRIDGE, MA, 02139

View on SEC.gov